The burgeoning popularity of tirzepatide , initially for blood sugar control , is creating significant interest within the UK , prompting a notable shift in medication trends. Access these compounds remains a complex landscape, with NHS approval currently limited and private clinics offering therapy at a substantial price. Worries are being raised